| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |